Rise in Demand from Water Treatment Industries Expected to Drive Corrosion Inhibitors Market over the Forecast Period: Ken Research

Buy Now

According to study, “Corrosion Inhibitors Market Research Report: by Product (Organic, Inorganic), by Application (Water-based Corrosion Inhibitors, Oil/Solvent Corrosion Inhibitors), by End-use Industry (Power Generation, Oil & Gas, Mining, Metal Processing, Chemical Processing, Others) and Region - Forecast to 2023” the key companies operating in the corrosion inhibitors market are Ashland, DowDupont, Air Products and Chemicals Inc., Acuro Organics Limited, Ganesh Benzoplast Limited, Solvay, Chemtex Specialty Limited, Ecolab Inc., Grace (WR) & Company, GCP Applied Technologies Inc., ICC Industries Inc., Henkel AG & Company KGAA, Freeport McMoran Inc., Innospec Inc., King Industries Inc., PQ Corp., Lanxess AG.

Corrosion is an oxidation reaction with an environment that results in dissolution of metal surface. Corrosion causes deterioration of metal. Corrosion inhibitors are substance or chemicals which form barrier between the environment and metal surface therefore preventing the corrosion. It is used to control & prevent corrosion in the production completion or conduit system. It is used extensively in the oil & gas and metal processing industries to decrease the rate of corrosion on metal surfaces by forming a protective film.

Based on product type, corrosion inhibitors market is segmented into organic inhibitors and inorganic inhibitors. Organic inhibitors include Benzotriazole, Organic Amines, Tolyltriazole, Phosphonates, and Mercaptobenzothiazole. Based on application, market is segmented into oil/solvent corrosion inhibitors and water based corrosion inhibitors. Water-based corrosion inhibitors segment holds largest share in market owing to lower volatile organic content (VOC) emissions as compared to solvent-based corrosion inhibitors. In addition, they are economical, turn transparent on drying, can be applied using various methods such as spray, brush, or immersion; and can be easily removed with water-based cleaners before subsequent operations. The oil-based segment is anticipated to witness higher growth rate due to its limited application scope, high flammability, and safety hazards during the forecast period. Additionally, based on end-use industry, market is segmented into power generation, metal processing, oil & gas, chemical processing and others. Power generation sector dominates the market as a result of growth in government investments for power generation projects and rise in generation of energy by consuming renewable sources for instance wind, solar, and hydro. Oil & gas sector is projected to be the fastest growing end-user segment on account of surge in product demand in pipelines as they decrease the losses incurred during refinement processes during the anticipated period.

The corrosion inhibitors market is driven by increase in demand for corrosion inhibitors in water treatment, followed by rise in demand for power generation, growth in regulations against wastewater discharge, surge in automotive sector and growth in construction sector. However, rise in use of thermoplastics in flow pipelines may impact the market. Moreover, growth in emphasis on green corrosion inhibitors &nano-materials and rapid industrialization in emerging economies are key opportunities for market.

Based on geography, the Asian-Pacific region holds major share in corrosion inhibitors market, followed by European region owing to rise in investment in oil & gas production and growth in demand for petroleum products, energy and fuel, in numerous applications in the region. The North-American region is projected to witness higher growth rate because of increase in shale gas extraction using hydraulic fracturing technology over the forecast period.

For more information on the research report, refer to below link:

Global Corrosion Inhibitors Market

Related reports

Global Corrosion and Scale Inhibitors Market Status (2015-2019) and Forecast (2020-2024) by Region, Product Type & End-Use

World Volatile Corrosion Inhibitors (VCI) Packaging Material Market Research Report 2024 (Covering USA, Europe, China, Japan, India and etc)

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91-9015378249

Interview of Naval Goel, Chief Executive Officer at PolicyX.com on insights of the Web Insurance Aggregators Market in India: Ken Research

“Winning Trust of Customers through Online Sales should be the objective of Insurance Web Aggregators in India”- Naval Goel, Chief Executive Officer at PolicyX.com Insurance Web Aggregator Private Limited.

By: Lakshay Aggarwal, Research Analyst Level II at Ken Research Private Limited

While top players in the industry have different priorities, starting from expanding customer base to achieving profitability, small and medium sized players are struggling to capture a piece of the pie. For understanding the right set of priorities of PolicyX.com, we reached out to Naval Goel, CEO at PolicyX.com, India.

This discussion was a part of the interview series “A Roadmap for India Web Aggregator Industry” and revolved around understanding the insights of the Web Insurance Aggregators Industry in India.

Here are some edited excerpts of the interview:

What was the idea behind starting PolicyX.com? What intrigued you to venture into this segment?

This idea came up to me while I was working with AIG in New York, USA. The insurance market dynamics in USA helped me to identify the unexploited opportunities in the insurance industry in India. So, when I came back to India, I started selling motor policies as an agent by hiring a few tele sales advisors. Over the course of time, I realized the archaic nature of technology deployed by Insurance Carriers then, which hindered the smooth functioning of agents. To simplify the process for agents, I tried to build a simple premium calculator for Insurance agents, helping them in generating quotations easily. PolicyX.com initially was supposed to be a calculator for the agents but later, we expanded to online lead generation and ultimately selling of policies.

What would be the major challenge that PolicyX.com faced during the journey?

As a price comparison website, we have to deal with many insurance carriers which differ in terms of operating procedures, different technological processes and offer varied products. Another major challenge is the compliance with the regulations set by IRDA. The regulations restricted the revenue streams, operational flexibility of web aggregators; ultimately restricting the growth of the industry. Since then, there have been lots of positive development in the regulatory framework and IRDA is working with the industry to improve it further.

What are the distributions channels opted by PolicyX.com to serve the customers?

PolicyX.com emphasizes on offering a user-friendly and transparent interface for the customers aiming to help consumers to buy insurance policies within few minutes. Around 2012-13, we thought of having an agent connected, POS model, for selling of policies. However, the regulations at that time did not support this and we had to drop the idea.

When asked about as to why PolicyX.com is now not venturing into the POS model, Naval replied “Competition is too fierce in the POS Model which does not lend a profitable opportunity to enter that space. Also, the regulations are not clear on whether a web aggregator can recruit agents. We aim to capitalize on the B2C market directly serving the customers through digital platform. We don’t see much competition from the POS model as far as the digital B2C market is concerned”.

What do you think should be the role assumed by Insurance Carriers in the coming years?

Insurance Carriers and other industry associations should focus on spreading awareness for different insurance products in the Tier-II and Tier-III cities. For instance, Life Insurance Council has launched a campaign “Sabse Pehle Life Insurance” serving the purpose of spreading awareness. There is a lot more to be done and I believe, industry players should collectively do it.

The stiff regulations imposed by IRDA in terms of restriction on cross-selling opportunities detriment the growth of revenue for aggregators. Do you think IRDA could relax such regulations?

The goal of IRDA is to protect consumer interest and specifically the customer data. We do not see any potential upliftment on restricted cross-selling opportunities or adding other financial products to the portfolio, in the near future.

What do you think about the entry of direct online insurance companies such as Acko in the Indian market? Would it pose a challenge to the Insurance Web Aggregators?

The insurance industry in India is very huge and entry of a single player cannot contribute or much affects the dynamics of aggregators. The direct online insurers might do well in B2B segment but the need for comparison by the individual customers would always be there. Therefore, entry of such new players is good for the overall Insurance Industry but does not pose a major challenge for the aggregators.

How does PolicyX.com plan to mitigate and survive the fierce competition in the industry?

Competition would always be there in the market and it is always prudent to focus on achieving economic returns of the business. Owing to the stringent regulations by IRDA, insurance aggregators are not allowed to increase prices or revenue streams, which leave the players with an option of becoming a cost-efficient player. PolicyX.com intends to continuously emphasize on profitability and keep up the tag of “Most Cost Efficient Player” in the industry.

Peer companies such as PolicyBazaar have recently expanded to UAE to provide scalability to their operations. Does PolicyX.com have any such plan of expanding geographically?

For the time being, we want to remain focused on Indian market, expanding our reach to Tier-II and Tier-III Cities.

PolicyX.com considers their biggest asset to be data driven technology while stating their topmost priority to be driving up the profitable growth, simultaneously aiming at enhancing our share in the industry.

For any queries or feedback, reach out to the author at lakshay@kenresearch.com.

The interview was conducted as a part of mapping the India Web Insurance Aggregator Industry.

To Find More Insurance Market Research Reports, refer to this link:-

https://www.kenresearch.com/banking-financial-services-and-insurance/insurance/SC-93-48.html

Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur@kenresearch.com
+91-9015378249

Landscape Of The Global Enterprise File Synchronization And Sharing Market Outlook: Ken Research

Buy Now

The enterprise file synchronization and sharing (EFSS) involve the software services which allow the organizations to synchronize and share a file, photos, documents, videos and many more, in a protected method, from the several devices to multiple the people such as external consumers, employees, and partners. In addition, the organizations often adopt such protected technologies to safeguard the employees from effectively utilizing the customer-based file sharing apps to store, access and maintain the corporate data that is beyond the IT department’s hold and visibility. The enterprise file-sharing items involve security abilities such as data encryption, authentication, containerization and tracking benefits to safeguard the data. Not only has this, but the EFSS also enables the files to be stored in an approved data repository which can be tenuously accessed by the employees from the personal computers, tablets, or the smartphones which suggest the EFSS good.

According to the report analysis, ‘Global Enterprise File Synchronization and Sharing (EFSS) Market (2018-2023)’ states that in the worldwide enterprise file synchronization and sharing (EFSS) market, there are numerous key players which recently functioning more effectively for leading the fastest market growth and registering the handsome value of market share around the globe throughout the short span of time while decreasing the issues related to the security and privacy of files and data, developing the applications of the product, determining the strategies and policies of the competitors and providing the better consumer satisfaction includes Dropbox, Box, Citrix, Microsoft, Google, Egnyte, Syncplicity by Axway, HighQ Solutions, Nextcloud, SkySync, and several others.

Although, the global EFSS market is anticipated to enlarge at a CAGR of 21% during 2018-2023, leading to global revenue of USD 10.35 Bn by 2023. Meanwhile, the risk related to security and privacy of files and data, incorporation, control, acquiescence, and regulatory issues are some of the explanations that may slow down the implementation of enterprise file sharing and synchronization among innumerable industry verticals and domains. According to Information Week, most organizations are impotent to wander all their files to Enterprise File Synchronization and Sharing, and NAS merchants have been slow to use the technology. These challenges often cause files to end up in numerous repositories.

However, IT can do away with reservations concerning unauthorized company file sharing, with the implementation of enterprise file sync and share. The Superintendents can set security parameters and generate the user account authorizations to limit approachability to sensitive data. Content is also characteristically encrypted when shared and scanned effectively utilizing the antivirus software to minimalize the risks of data leaks. These benefits effectively increase the implementation of EFSS solutions and services in organizations. The execution of the Bring-Your-Own-Device (BYOD) programs in organizations, the increasing dissemination of smartphones across businesses, positive augment in the mobile workforce, growing collaboration between employees and enterprises, and stringent government guidelines for data security are some of the drivers of the EFSS market. Therefore, it is anticipated that in the coming years the market of enterprise file synchronization and sharing market will increase around the globe more positively over the near years.

To Know More, Click On The Link Below:-

Global Enterprise File Synchronization And Sharing Market

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91-9015378249

Rise in Concerns for Patient Safety in Hospitals Anticipated to Drive Global Isolation Amplifier Market over the Forecast Period: Ken Research

Buy Now

Isolation amplifiers are components with dual purposes of amplification & safety. It is equipped with a delta-sigma analog-to-digital (AD) converter which helps in detecting infinitesimal electric current & voltage fluctuation with high precision. It provides grounding, insulation, and data isolation by providing a barrier of electrical safety & electrical isolation. It protects the patients from leakage currents and also protects data acquisition components from common mode voltages. It is used for amplifying low-level signals in multi-channel applications. It may include isolated power supplies for both the output and input stages, or may use external or peripheral power supplies on each isolated portion. It is commercially available as hybrid integrated circuits made by numerous manufacturers. Some methods of providing isolation are optically isolated amplifier, transformer-isolated amplifier and capacitive isolation amplifier.

The key advantages are included high linearity, high gain stability & linearity, avoids device & radiated noise and conducted noise, improves patient safety, high common mode rejection ratio and high accuracy.

According to study, “Global Isolation Amplifier Market, By Application (Medical (ECG and EEG), Industrial (Industrial Process Control, Current Shunt Measurement and Others (Nuclear and Telecommunication)), By Type (Analog and Digital), By Region - Forecast to 2023” the key companies operating in the global isolation amplifier market are Silicon Laboratories, Inc., Wurth Elektronik, Dewetron GmbH, DRAGO Automation GmbH, Broadcom Pte. Ltd., Toshiba Corporation, Analog Devices Inc., Eaton Corporation PLC, Texas Instruments Inc.

Based on type, isolation amplifier market is segmented into digital and analog. The digital isolation amplifier segment is anticipated to be the biggest revenue generator due to transition of customers to faster data speed and change in communication networking technologies during the forecast period. Based on product type, market is segmented into capacitor isolated amplifiers, optoelectronic isolated amplifiers and transformer isolated amplifiers (electromagnetic isolated amplifiers). In addition, based on application, market is segmented into industrial, medical, sewage treatment, nuclear (input/output/power isolation), electronics, telecommunication and others. Industrial sector includes industrial process control, current shunt measurement and others. Medical sector includes Electrocardiography (ECG), electroencephalogram (EEG) and others. Medical segment dominates the market owing to growth in demand for amplifiers in maintaining the stability of equipment.

The isolation amplifier market is driven by rise in concerns for patient safety in hospitals & medical institutions, followed by growth in demand for noise cancellation & data protection in telecommunication. However, high pricing of wide bandwidth 3-port isolation amplifier for numerous industrial applications may impact the market. Moreover, increase in adoption of isolated amplifier in optical isolation with fiber optic transmission is a key opportunity for market.

Based on geography, the North-American region holds major share in isolation amplifier market owing to rise in technological advancements, increase in well-established industries such as telecommunication, automotive, and healthcare sectors and growth in demands a well-structured industry in the region. The European and Asian-Pacific regions are estimated to witness higher growth rate due to high development in the field of technology and presence of developing nations over the forecast period. It is predicted that future of the market will be bright because of presence of global players and rapid urbanization during the forecast period.

For more information, click on the link below:

Global Isolation Amplifier Market

Contact Us:    

Ken Research                                   

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91 9015378249

Growth in Prevalence of Autoimmune Diseases Estimated to Drive Global Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market: Ken Research

Buy Now

Chronic inflammatory demyelinating polyneuropathy or CIDP is a neurological disorder in which the body immune system attacks myelin which is a vital part of the nervous system. It occurs when the body immune system cannot distinguish between the body’s own cell and foreign cell and instead start destroying the healthy cells of the body. It is also known as chronic relapsing polyneuropathy. This can cause impaired ability, pain, loss of sensation, chronic fatigue and other problems, Different treatments can be used to treat the disease for instance intravenous immunoglobulin, physiotherapy, plasmapheresis, and others.

Some of the symptoms are both proximal and distal, orthostatic dizziness, initial limb weakness, tingling and numbness of hands & feet.

According to study, “Global Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Information By Treatment (Intravenous Immunoglobulin, Corticosteroids, Plasmapheresis (Plasma Exchange), Physiotherapy, Others), Diagnosis (Electrodiagnostic Testing, Nerve Conduction, EMG, Spinal Fluid Analysis, Others), By Route of Administration (Intravenous, Oral, Others), By End User (Hospitals, Specialty Neurological Clinics, Research & Academic Laboratories, Others) and Top Regions Forecast till 2023” the key companies operating in the global Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) market are Octapharma AG, Shire, Kedrion S.p.A, Mitsubishi Tanabe Pharma Corporation, Grifols, Baxter, Momenta Pharmaceuticals Inc., Argenx SE, Immupharma Plc., Pfizer Inc., GeNeuro SA, Teijin Pharma Ltd, Takeda Pharmaceutical Co Ltd., UCB SA.

Based on treatment, Chronic Inflammatory Demyelinating Polyneuropathy market is segmented into intravenous immunoglobulin (IVIG), plasmapheresis (plasma exchange), corticosteroids, physiotherapy and others. IVIG segment dominates the market owing to its preference as the first line of treatment against CIDP. Based on diagnosis, market is segmented into electro-diagnostic testing, EMG, nerve conduction, spinal fluid analysis and others. Based on route of administration, market is segmented into oral, intravenous and others. Based on distribution channel, market is segmented into retail pharmacy, hospital pharmacy and online pharmacy. In addition, based on end-user, market is segmented into hospitals, research & academic laboratories, specialty neurological clinics and others.

The Chronic Inflammatory Demyelinating Polyneuropathy market is driven by rise in research & development (R&D) related to plasma-derived medicines, followed by growth in prevalence of autoimmune diseases, rise in government support via awareness programs & drug approvals and increase in awareness about Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). However, high cost of the IVIG treatment and side-effects associated with the IVIG treatment such as hypotension, lower back pain, flushing, nausea, chills, wheezing, etc. may impact the market. Moreover, growth in advancements in the treatment is a key opportunity for market.

Based on geography, the North-American region holds major share, followed by European region in Chronic Inflammatory Demyelinating Polyneuropathy market owing to growth in healthcare infrastructure and active government support in the region. The Asian-Pacific region is anticipated to witness lucrative growth rate due to rise in emphasis by healthcare organizations & government over the forecast period. It is projected that the market will be reached at rapid pace on account of high population & growth in per capita healthcare spending and increase the prevalence rate of CIDP during the forecast period. The market is developing at a CAGR of 6.2% and is estimated to reach US $3907.17 million by the end of the forecast period 2018-2023.

To know more, click on the link below:-

Global Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market

Related Reports:-

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Trials Review, H1, 2019

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)-Pipeline Review, H2 2017

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

ankur@kenresearch.com

+91-9015378249

Surge in Mining Activities Anticipated to Drive Submersible Global Pumps Market over the Forecast Period: Ken Research

Submersible pump is a device or equipment that can be fully submerged in water. It is also known as sub pump or electric submersible pumps (ESP). It is hermetically sealed & close-coupled to the body of the pump. It pushes water to the surface by converting rotary energy into kinetic energy and into pressure energy.

The key advantages are handle solids as well as liquids, very efficient, never has to be primed, produce less amount of noise, safe and quiet in water. Besides this, some of the disadvantages are pump failure cannot notice quickly and high cost.

According to study, “Submersible Pumps Market Research Report: by Industry (Water & Wastewater, Oil & Gas, Agriculture & Irrigation, Construction, Mining, Others), by Well Type (Bore Well, Open Well), by Operation (Multi Stage, Single Stage), by Power Rating (High Power, Medium Power, Low Power), and Region - Forecast to 2023” the key companies operating in the submersible pumps market are Grundfos Group, Xylem Inc., KSB Group, Ebara Corporation, Tsurumi Manufacturing Co. Ltd., The Weir Group PLC, Atlas Copco AB, Sulzer Ltd., Flowserve Corporation, Halliburton Company, General Electric Company, The Gorman-Rupp Company, Wilo SE, ITT Goulds Pumps, Walrus Pump Co., Ltd., Toyo Denki Industrial Co., Ltd.

Based on type, submersible pumps market is segmented into open-well submersible pump, bore-well submersible pump and non-clog submersible pump. Based on drive type, market is segmented into hydraulic type, electric type and others. Based on head, market is segmented into below 50 m, between 50 m to 100 m and above 100 m. Based on operation type, market is segmented into single-stage operation and multistage operation. Single stage pump is used for sewage pumping, drainage, slurry pumping and general industrial pumping while multiple stage pumps are used for water wells, water abstraction and in oil wells. Based on power rating, market is segmented into high power, medium power and low power. Based on application, market is segmented into agriculture sector, industrial sector and domestic sector. In addition, based on end-use industry, market is segmented into mining & construction, energy & power, oil & gas, water & wastewater and other industries. The oil & gas industry holds largest share owing to rise in production from wells, increase in capital expenditure, growth in production of a large amount of wastewater and increase in exploitation of shale reserves.

The submersible pumps market is driven by growth in urbanized population, followed by rise in infrastructure investments, high preference of submersible pumps, surge in mining activities and increase in industrialization. However, high troubleshooting cost and failure of submersible motors may impact the market. Moreover, surge in subsea operations and increase in deep water exploration activities & subsea operations are key opportunities for market.

Based on geography, the Asian-Pacific region dominates the submersible pumps market, followed by North-American region owing to rise in government policies and expansion of construction and oil & gas industries in the region. The European region is expected to witness considerable growth rate due to rise in investments on the sewage water treatment & drinking water treatment plant overt he forecast period. It is predicted that future of the market will be bright on account of expand in the capacity of existing facilities during the forecast period.

For more information, refer to below link:-

Global Submersible Pumps Market

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91-9015378249

Insights Of The Global Non-Alcoholic Steatohepatitis Market Outlook: Ken Research

Buy Now

The worldwide epidemic of type 2diabetes and increasing obesity are leading to the increasing prevalence of non-alcoholic steatohepatitis (NASH), particularly in the developed economies. According to the NASH Education The program, NASH distresses approximately 12% of the world's adult populace. More than 80% of patients with NASH are obese, 44% have type 2 diabetes, and 72% have abnormal blood lipids (triglycerides and cholesterol). The effective rise in the prevalence of these ailments is anticipated to foster the requirement for the NASH diagnostics over the 2018-2023 periods.

In addition, the programs, and initiatives to effectively increase awareness are predicted to positively foster market growth over the forecast duration. In 2016, The NASH Education Program was developed with the objective of spreading consciousness among medical practitioners, patients identified with NASH, and personalities at high risk of developing it. On the other hand, augmenting the investments for the development of precise, reliable and willingly obtainable diagnostic tests for NASH is expected to foster the market over the forecast duration.

According to the report analysis, ‘Global Non-alcoholic Steatohepatitis (NASH) Diagnostics Market (2018-2023)’ states that in the worldwide Non-alcoholic Steatohepatitis (NASH) diagnostics market, there is an effective number of players for leading the fastest market growth and registering the handsome value of market share around the globe during the short span of time while developing the benefits of the product, leading the consciousness across the globe throughout the short span of time, delivering better consumer satisfaction and decreasing the cost of productivity includes GENFIT SA, Echosens, SuperSonic Imagine, BioPredictive, One Way Liver, S.L. (OWL), VLVbio AB, Quest Diagnostics Incorporated, Prometheus Laboratories Inc., Siemens Healthcare GmbH, Exalenz Bioscience Ltd., and several others.

Additionally, based on the diagnostic techniques segment, the Liver biopsy is one of the widely adopted diagnostic techniques for NASH detection since it delivers accurate results. The Liver biopsy is favored by the medical consultants due to its capability to regulate the degree of steatosis and inflammation correctly. However, the aggressive liver biopsy process has numerous disadvantages, such as pain, bleeding, and the opportunity of injuring other organs. Thus, the implementation of the non-invasive imaging techniques and biomarkers is predicted to augment significantly. As a result, the market size of the liver biopsy technique is anticipated to increase at a leisurelier rate than biomarkers, in developed economies like North America and Europe.

For instance, the great cost of NASH diagnosis through liver biopsy is hindering the growth of the market in developing economies like Latin America and Asia-Pacific. On the basis of regional insights, North America controlled the principal share of the NASH diagnostics market. The increasing pervasiveness of obesity and type 2 diabetes is leading to an augmenting the number of patients anguish from NASH in the United States (U.S.) and Canada. NASH has been described to be the second-most common source for liver transplantations in the U.S. By 2020, it is anticipated to exceed hepatitis C as the leading cause of liver transplants. Not only has this, but the Asia-Pacific is also predicted to be the fastest increasing market owing to the growing awareness among patients and developing the healthcare infrastructure. Therefore, in the coming years, it is predicted that the market of non-alcoholic steatohepatitis diagnostic will increase around the world more positively over the near years.

Companies covered:-

GENFIT SA

Echosens

SuperSonic Imagine

BioPredictive

One Way Liver

VLVbio AB

Quest Diagnostics Incorporated

Prometheus Laboratories Inc

Siemens Healthcare GmbH

Exalenz Bioscience Ltd

To Know More, Click On The Link Below:-

Global Non-Alcoholic Steatohepatitis Market

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91-9015378249

Profitable Landscape Of The Market Outlook: Ken Research

Buy Now

The Clinical informatics is perceptibly restructuring the healthcare services for the better by amalgamating information technology (IT) with the informatics. It centrals to better interoperability and augmented the digitization, concluding in proficient patient data maintenance and developed treatment processes, by effectively suggesting physicians create informed decisions. All of such aspects will ultimately modernize the market of the healthcare.

According to the report analysis, ‘Global Clinical Informatics Market (2018-2023)’ states that in the worldwide clinical informatics market, there are numerous key players which recently functioning more positively for leading the fastest market growth and registering the handsome value of market share around the globe while expanding the premises, developing the applications of the product, delivering the better protection, spreading the effective awareness and employing the skillful or intellectual employees includes Cerner Corp, Agfa HealthCare Corp,Allscripts, Cardinal Health, CNSI,Amcom Software (Spok, Inc.),Meditech,eClinicalWorks, Nuance Communications, West Corporation and several others.

The worldwide clinical informatics market is predicted to be worth USD 33.31 Bn in 2023, and is anticipated to enlarge at a compound annual growth rate (CAGR) of 18.26% during the forecasted period of 2018-2023.

Based on the application sector, the diagnostics market had the principal share in 2017, subsidizing to 39% of the market revenue. The growth of the diagnostics sector has principally been fostered by augmenting the popularity of non-invasive procedures, advanced visualization systems, and technological development in clinical informatics products. It is anticipated to observe the highest CAGR (18.41%) among all the application sector during the forecasted duration. In terms of growth impending, the diagnostics market will be monitored by the patient monitoring sector (CAGR of 18.30%).

Furthermore, on the basis of technology sector, the on-premises software market controlled the principal market share of about 58% in 2017, primarily owing to its extensive convenience and usage. On the other hand, the cloud-based software sector is predicted to enlarge at a sophisticated CAGR of 19.63% during the reviewed period of 2018-2023. This extraordinary growth can be accredited to the augmented acceptance of the cloud-based platforms, which can deliver the better security, storage, and effectiveness.

Additionally, according to the end user sector, in 2017, the hospitals sector had a worldwide market share of around 38%, and is predicted to involvement the highest growth rate (18.58%) during the 2018-2023 duration. This is because of progressively strict but favorable government policies that command the employment of electronic health records (EHR) around the hospitals, coupled with funding and inducements. The 'physicians' sector is also anticipated to observe the significant growth. The specialty centers sector controlled roughly 10% of the total market share, while the research laboratories sector controlled 15%.

Not only has this, the regional insights states that the North America has been prominent the market with its technological innovations, registering for around 50% of the global market. However, the Asia-Pacific is predicted to have the wildest growth rate during the forecasted duration owing to the augmented requirement for the healthcare services in this economy. The effective increase in the number of patients, augmenting the government funding for health-related IT services, and health consciousness are aspects which will lead to the growth of the market in the region. Therefore, in the coming years, it is anticipated that the market of clinical informatics will increase around the globe more positively over the near years.

For more information on the research report, refer to below link:

Global Clinical Informatics Market

Related report

Global NGS Informatics and Clinical Genomics Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91-9015378249

Growth in Rate of Pregnancy Anticipated to Drive Global Mastitis Market over the Forecast Period: Ken Research

Mastitis is an acute inflammation of an interlobular connective tissue within the mammary gland. The inflammation results in swelling, warmth, breast pain, and redness. It most commonly affects women who are breast-feeding (lactation mastitis). Milk trapped in the breast is a main cause of mastitis. Some other causes are bacteria enter in breast and blocked milk duct.

Some of the signs and symptoms are breast tenderness or warmth to the touch, thickening of breast tissue or a breast lump, breast swelling, skin redness often in a wedge-shaped pattern, generally feeling ill, pain or a burning sensation continuously or while breast-feeding and fever of 101 F (38.3 C) or greater. Besides this, few of the risk factors include previous bout of mastitis while breast-feeding, improper nursing technique, sore or cracked nipples, poor nutrition, and becoming overly tired or stressed.

According to study, “Mastitis Market Research Report Information by Type (Human, Bovine), by Treatment (Antibiotics, Pain Relievers, Surgery, Vaccines, Others), by End-user (Hospitals and Clinics, Veterinary Centers, Others) and Region - Global Forecast till 2023” the key companies operating in the mastitis market are Merck Co & Inc., Pfizer Inc., Astellas Pharma Inc., Novartis AG, Bayer AG, Oncothyreon Inc., BioNumerik Pharmaceuticals Inc., Oncogenex, Apthera Inc., Boehringer Ingelheim GmbH, Zoetis Inc.

Based on type, mastitis market is segmented into bovine and human. Bovine type includes environmental mastitis, contagious mastitis and opportunist mastitis. Human type includes infectious mastitis and non-infectious mastitis. Based on treatment, market is segmented into surgery & radiation therapy, chemotherapy, biologic therapy, targeted therapy and hormone therapy. Chemotherapy treatment includes anthracyclines, antimetabolites and taxanes & alkylating agents. Targeted therapy includes tyrosine kinase inhibitors &monoclonal antibodies. Additionally, Hormone therapy includes aromatase inhibitors and selective estrogen-receptor modulators (SERMs). In addition, based on end-user, market is segmented into hospital & clinics and veterinary centers.

The mastitis market is driven by growth in rate of pregnancy, followed by rise in cases of breast cancer increase in prevalence of mastitis among the bovine population, rise in government initiatives to promote healthy breastfeeding, and unhygienic barn conditions causing contagious mastitis in bovines. However, rise in complications in diagnosis owing to similar symptoms of breast cancer & mastitis and lack of awareness among people may impact the market. Moreover, growth in developing economies is a key opportunity for market.

Based on geography, the Asian-Pacific region holds major share in mastitis market owing to rapidly developing the economy, huge healthcare spending, rise in availability of technology, growth in government initiatives for research & development (R&D) and increase in healthcare expenditure in the region. The North-American and European regions are estimated to witness considerable growth rate due to growth in technological advancement in the healthcare and increase in number of patient population for mastitis over the forecast period. In upcoming years, it is projected that the market will be reached at quick speed on account of increase in focus of various government agencies on treating mastitis during the forecast period. The global market is growing at a CAGR of 15.07% by directing the value of US $7,898.05 million during the forecast period (2017-2023).

For more information, refer to below link:-

Global Mastitis Market

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91-9015378249